Background

The activation of T-cell receptors (TCRs) is a critical component of the adaptive immune response, driven by the interaction between TCRs and peptide-major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs). Understanding this interaction is pivotal for developing improved checkpoint and cell-based immunotherapies. To support this research, we have developed engineered cell lines and constructs to characterize antigen specificity and identify epitopes.

  • The Jurkat TCR Knockout Cell Line (Jurkat TCRa/b-Knockout, CD8 Cells, Clone) was developed by CRISPR/Cas9-mediated knockout of the TRAC and TRBC genes in Jurkat E6.1 cells. The inactivation of TRAC/TRBC was confirmed via sequencing and negative staining with a PE-labeled anti-human TRBC1 antibody (Figure 1), which targets the TCR protein.
  • The Jurkat TCR Knockout NFAT-GFP Reporter Cell Line (Jurkat TCRa/b-Knockout NFAT-tagGFP2 CD8, Clone) was transduced with GFP reporter construct expressing TCR: NFAT–mCMV–GFP–EF1–CD8 (Figure 2). Clonal selection was performed to isolate the cell line that showed the highest level of GFP expression—up to a 1,000-fold increase—after stimulation with PMA + ionomycin, indicating strong reporter activation.
  • The K562 HLA-A-02:01 Cell line (Bleo or Puro, Polyclonal) was developed by engineering K562 cells to express the HLA-A-02:01 complex.

Fig 1. Construction of Jurkat-NFAT-GFP reporter cell line.

Fig 2.Map for NFAT-mCMV-GFP Reporter Construct

Applications:

  1. TCR Cloning and Evaluation:
    Jurkat TCR-Reporter Cells engineered to express TCRs can be used to analyze the specificity and affinity of both native and engineered TCRs.
  1. Antigen Screening:
    Libraries of specific peptides can be screened against TCR-expressing Jurkat TCR-reporter cells to identify those recognized by particular TCRs, as well as analysis of antibodies or small molecules that can mimic or inhibit TCR activation.
  1. T Cell Signaling Studies:
    Jurkat TCR-Reporter Cells can be used to study T-cell pathway responses to tumor- or virus-specific antigens and to dissect the molecular mechanisms underlying T-cell activation

Please read the entire user manual before proceeding with your experiment.

 


PLEASE NOTE: The purchase of all Cellecta Products is covered by Cellecta’s standard Terms and Conditions of Sale as described on Cellecta’s website, and selected Products containing particular technology or having certain features are also subject to restrictions on use as outlined in the Label License section of our website. Please review these Terms and Label License Restrictions before opening and using your Product and if you are not able to abide by the restriction, contact Cellecta to return the item to Cellecta for a full refund.


Last modified: 19 September 2025

Need more help with this?
Don’t hesitate to contact us here.

Thanks for your feedback.